Preclinical screening and analysis of the immunotoxic and immunomodulatory activity using a multiple immunoassay (MIA) in mice
Language English Country Great Britain, England Media print
Document type Journal Article
PubMed
2105913
DOI
10.1016/0192-0561(90)90063-s
PII: 0192-0561(90)90063-S
Knihovny.cz E-resources
- MeSH
- Adjuvants, Immunologic pharmacology MeSH
- Lymphocyte Activation drug effects MeSH
- Cyclophosphamide pharmacology MeSH
- Dexamethasone pharmacology MeSH
- Phagocytosis drug effects MeSH
- Thyrotropin-Releasing Hormone pharmacology MeSH
- Immunoassay * MeSH
- Immunosuppressive Agents pharmacology MeSH
- Listeria monocytogenes immunology MeSH
- Macrophages drug effects MeSH
- Antibodies, Monoclonal immunology MeSH
- Mice, Inbred C57BL MeSH
- Mice MeSH
- Drug Evaluation, Preclinical MeSH
- Antibody Formation drug effects MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Adjuvants, Immunologic MeSH
- Cyclophosphamide MeSH
- Dexamethasone MeSH
- Thyrotropin-Releasing Hormone MeSH
- Immunosuppressive Agents MeSH
- Antibodies, Monoclonal MeSH
Screening and analysis of immunotoxic and immunomodulatory activity has become an integral component in preclinical studies of pharmaceuticals and xenobiotics. In an attempt to replace laborious and expensive batteries of assays used at present we developed a multiple immunoassay (MIA) enabling the determination, in a single mouse, of: the weight of the thymus, spleen and a group of lymph nodes; delayed type hypersensitivity and antibody response to SRBC; phagocytic activity of peritoneal macrophages and the responsiveness of spleen lymphocytes to "T" (PHA, ConA) and "B" (LPS) mitogens in vitro. The MIA responsiveness to two prototype immunostimulators (Thymostimulin and Listeria factor Ei) was tested at two time periods after antigenic stimulation, not only in normal mice, but also in animals with selectively depressed T-systems (anti-Thy1.2 monoclonal antibody) and B-systems (cyclophosphamide); in both dexamethasone-treated and irradiated animals. The findings indicate, that this MIA is capable of reflecting both immunosuppressive and immunostimulatory activities of the tested agents and permits partial insight into the mechanisms underlying these activities.
References provided by Crossref.org